GlobalData, the industry analysis specialist’s new report, "Osteoarthritis – Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global osteoarthritis market. The report identifies the key trends shaping and driving the global osteoarthritis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global osteoarthritis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Scope

The report analyzes market opportunities and challenges for the global osteoarthritis market. Its scope includes

• Annualized global osteoarthritis market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.

• Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.

• Pipeline analysis data providing a split across different phases by mechanism of action being developed and emerging trends. Key classes of mechanism of action include serotonin-norepinephrine reuptake inhibitors, calcium homeostasis regulators, and proton pump inhibitors, inhibitor of 5-lipoxygenase and cyclooxygenase, opioid receptor agonist, stem cell therapy, cartilage cell synthesizer.

• Analysis of the current and future market competition in the global osteoarthritis market. Key market players covered are Novartis AG, Pfizer, Inc., Johnson & Johnson and Abbott Laboratories

• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

• Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with osteoarthritis market.

Reasons to buy:

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

• Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

• Develop business strategies by understanding the trends shaping and driving the global osteoarthritis market.

• Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global osteoarthritis market in future.

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

• What’s the next big thing in the global osteoarthritis market landscape? – Identify, understand and capitalize.

Table of contents

1 Table of contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Osteoarthritis Market: Market Characterization 5

2.1 Overview 5

2.2 Osteoarthritis Therapeutics Market Size 5

2.3 Osteoarthritis Market Forecast and CAGR 6

2.4 Drivers and Barriers for the Osteoarthritis Therapeutics Market 7

2.4.1 Drivers for the Osteoarthritis Therapeutics Market 7

2.4.2 Barriers for the Osteoarthritis Therapeutics Market 8

2.5 Opportunity and Unmet Need 8

2.6 Key Takeaway 9

3 Osteoarthirtis Market: Competitive Assessment 10

3.1 Overview 10

3.2 Strategic Competitor Assessment 10

3.3 Product Profiles of the Major Marketed Products in the Osteoarthritis Therapeutics Market 11

3.3.1 Voltaren Gel 11

3.3.2 Celebrex 11

3.3.3 Hyalgan 12

3.3.4 Mobic 12

3.4 Key Takeaway 13

4 Osteoarthritis Market: Pipeline Assessment 14

4.1 Overview 14

4.2 Strategic Pipeline Assessment 14

4.2.1 Technology Trends Analytic Framework 14

4.3 Osteoarthritis Therapeutics – Promising Drugs under Clinical Development 15

4.4 Molecule Profile for Promising Drugs under Clinical Development 16

4.4.1 SD6010 16

4.4.2 PF-4383119 16

4.4.3 TDS-943 16

4.4.4 SMC021 17

4.4.5 CG5503 17

4.4.6 Vicodin CR 18

4.5 Osteoarthritis Market – Clinical Pipeline by Mechanism of Action 18

4.6 Osteoarthritis Pipeline – Pipeline by Clinical Phases of Development 19

4.6.1 Osteoarthritis Therapeutics – Phase III Clinical Pipeline 20

4.6.2 Osteoarthritis Therapeutics – Phase II Clinical Pipeline 23

4.6.3 Osteoarthritis Therapeutics – Phase I Clinical Pipeline 25

4.6.4 Osteoarthritis Therapeutics – Discovery Pipeline 26

4.6.5 Osteoarthritis Therapeutics – Discontinued Pipeline 26

4.7 Key Takeaway 26

5 Osteoarthritis Market: Implications for Future Market Competition 27

6 Osteoarthritis Market: Future Players in the Osteoarthritis Market 28

6.1 Introduction 28

6.2 Novartis Pharma AG 28

6.2.1 Overview 28

6.2.2 Osteoarthritis Disease Portfolio 29

6.2.3 SMC021 29

6.3 Pfizer Inc. 29

6.3.1 Overview 29

6.3.2 Osteoarthritis Disease Portfolio 30

6.3.3 SD6010 30

6.3.4 PF-4383119 30

6.3.5 TDS-943 31

6.4 Johnson and Johnson 31

6.4.1 Company Overview 31

6.4.2 Osteoarthritis Disease Portfolio 32

6.4.3 CG5503 32

6.5 Abbott Laboratories 32

6.5.1 Company Overview 32

6.5.2 Osteoarthritis Disease Portfolio 33

6.5.3 Vicodin CR 33

7 Osteoarthritis Market: Appendix 34

7.1 Definitions 34

7.2 Acronyms 34

7.3 Research Methodology 34

7.3.1 Coverage 35

7.3.2 Secondary Research 35

7.3.3 Forecasting 36

7.3.4 Primary Research 38

7.3.5 Expert Panel Validation 39

7.4 Contact Us 39

7.5 Disclaimer 39

7.6 Sources 39